Dr Reddy's gets nod to launch Zafirlukast

22 Nov 2010 Evaluate

Dr Reddy’s Laboratories has launched Zafirlukast tablets (10 mg and 20 mg), a bioequivalent generic version of Accolate in the US market.

Zafirlukast is a prescription medicine used for treating asthma. According to IMS Health, the medicine had total US sales of approximately $50 million for the 12 months ending August 31, 2010.On November 15, 2010, the US District Court of New Jersey granted Dr Reddy’s motion for summary judgment of non-infringement against AstraZeneca clearing the way for the launch of the product.

Subsequently, the Food & Drug Administration (FDA) approved Dr Reddy’s ANDA (abbreviated new drug application) for Zafirlukast tablets on November 18. The company’s tablets are available in bottles of 60 counts.crackcrack

Dr. Reddys Lab Share Price

1194.55 -19.40 (-1.60%)
21-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1777.65
Dr. Reddys Lab 1194.55
Cipla 1465.65
Lupin 2043.30
Zydus Lifesciences 944.25
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.